Lipid Stabilized Solid Drug Nanoparticles for Targeted Chemotherapy.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology
• Pharmacology

Background:

• Nanoparticle-based chemotherapeutics offer tunable pharmacokinetics and pharmacodynamics for improved drug delivery.
• Existing nanoparticle formulations, such as liposomes and polymers, often have limited drug payloads (typically <10%).
• There is a need for scalable and efficient methods to create high-payload drug nanoparticles.

Purpose of the Study:

• To develop a general and scalable approach for preparing lipid-coated solid drug nanoparticles.
• To overcome the low drug payload limitations of current nanoparticle drug delivery systems.
• To evaluate the efficacy of these novel nanoparticles in a preclinical cancer model.

Main Methods:

• A combined approach of flash nanoprecipitation and extrusion was employed to create lipid-coated solid drug nanoparticles.
• This method allows for separate optimization of individual preparation steps and flexibility in surface functionalization.
• Methotrexate was used as a model drug for nanoparticle formulation and evaluation.

Main Results:

• The developed method successfully produced lipid-coated solid drug nanoparticles with potentially higher drug payloads.
• Methotrexate-loaded nanoparticles demonstrated significantly enhanced tumor growth suppression compared to free methotrexate.
• The approach offers scalability and flexibility for creating diverse nanoparticle surface functionalities.

Conclusions:

• The flash nanoprecipitation and extrusion technique provides a scalable and versatile platform for producing high-payload drug nanoparticles.
• Lipid-coated solid drug nanoparticles represent a promising advancement in cancer chemotherapy, outperforming conventional free drug administration.
• This technology has the potential to improve therapeutic outcomes in cancer treatment by enhancing drug delivery efficiency.